|
|
|
| |
|
| |
Obstetrics & Gynecology
Residency Program
Publications & Presentations |
| |
|
| |
|
| |
|
| |
Publications, Presentations, Misc. |
| |
|
| |
 |
Khaled Sakhel, M.D., Pregnancy outcomes after intrauterine insemination in patients with ovulatory disorder. Research Day Presentation. May 2007. |
| |
|
|
American Association of Gynecologic Laparoscopists. Oral Presentation. 2006. Clinical Presentations may alter the Accuracy of Sonohysterography - The Results of a Cohort Study.
Sakhel K, Fanelli L, Fourment C, El Mokadem H, Wagner A. |
| |
|
|
ACOG/ELI Lilly Research Award: The Effect of Calcium and Vitamin D on the Change in Bone Mineral Density in Patients on Depo Medroxy Progesterone Acetate for Birth Control. 2006-present. Thomas A. Raskauskas, MD, Chris Rohr, DO and Khaled Sakhel, MD,. |
| |
|
|
Dr. Sakhel appointed 2007 APGP Medical Education Foundation Scholar |
| |
|
| |
Trends, Predictors, and Comparison of Episiotomy Use Amongst Residents and Community Faculty at Covenant HealthCare. 2005-present. Thomas A. Raskauskas, MD and Dama Ziworitin, MD. |
| |
|
| |
Heavy Metal Mesurements in the Newboarn: A Pilot Study. 2005-present. Thomas A. Raskauskas, MD, Joe-la Dowdy, DO, and Brent Speak, DO, . |
| |
|
|
Cherukuri, R., Moon, H., Pattan, R., Wechter, D., et. al.,
Objectives for a Clinical Experience in Obstetrics and Gynecology,
Michigan state University, The Department of Obstetrics, Gynecology
and Reproductive Biology, 5th edition, 2002. |
| |
|
|
| |
|
| |
Accepted Abstracts |
| |
| |
|
|
Khaled Sakhel, MD, Reproductive outcome after hysteroscopic in women with primary infertility. Oral Presentation during ASRM 2007. |
|
|
|
Khaled Sakhel, MD, The effects of GnRH anatagonist versus GnRH agonist down regulation on the outcome of IUI cycles. Poster presentation at ASRM 2007. |
|
| |
|
| |
|
| |
Ongoing Clinical Trials |
| |
|
| |
| |
Duramed Research - Secondary Amenorrhea (Feb 2006 - Mar 1, 2007)
A Phase II, multicenter, double-blind, randomized placebo controlled study to evaluate induction of withdrawal bleeding after administration of oral micronized progesterone in women with secondary amenorrhea.
Principle Investigator: Thomas Raskauskas, MD. Sub-Investigator: Ronald Hazen, MD, Henry Moon, MD, Davis Dhas, MD. |
| |
|
| |
Berlex - Idiopathic Menorrhagia (Feb 2006 - 2/9/2007)
A multicenter, randomized, open label, parellel group, active control study to evaluate the efficacy and safety of LNG IUS mirena as compared to medroxyprogesterone acetate during 6 cycles of treatment in patients with idiopathic menorrhagia.
Principle Investigator: Thomas Raskauskas, MD. Sub-Investigator: Ronald Hazen, MD, Henry Moon, MD, Davis Dhas, MD. |
| |
|
| |
Watson - Over Active Bladder (Sept 2006 - 2/15/2007)
A multi-center, double-blind, placebo-controlled study of the efficacy and safety of daily dosing with oxybutynin topical gel to treat the symptoms of overactive bladder.
Principle Investigator: Ronald Hazen. Sub-Investigator: Rebecca Baumbach, MD, Thomas Raskauskas, MD, Henry Moon, MD, |
| |
|
| |
Hormos-Vaginal Atrophy (April 2006 - 1/31/2007)
Efficacy and safety of ospemifene in the treatment of vulvar and vaginal atrophy (VVA) in postmenopausal women: A 12-week, randomized, double-blind, placebo-controlled, parallel-group study comparing oral ospemifene 30 mg, and 60 mg daily doses with placebo.
Principle Investigator: Thomas Raskauskas, MD. Sub-Investigator: Rebecca Baumbach, MD. |
|
| |
|
| |
|
|
